A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors
Clinical trial NCT01731925 · UNKNOWN
Trial details
- NCT number
- NCT01731925
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-07
- Primary completion
- 2017-12-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.